Immunisation with gp160 in HIV-1 infection.
Pontesilli
O
O
Aiuti
F
F
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D019380:Anti-HIV Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D019302:HIV Envelope Protein gp160 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000628:therapy; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D016896:Treatment Outcome; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology*
D016915:AIDS Vaccines; D019380:Anti-HIV Agents; D019302:HIV Envelope Protein gp160; D014614:Vaccines, Synthetic